Acquisisci rapidamente informazioni dai migliori esperti e guadagna crediti CME/CE con programmi coinvolgenti per oncologi e ematologi. Rimani aggiornato sulle principali innovazioni e casi di studio.
Jesus G. Berdeja, MD - Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma With Bispecific Antibodies: A Community Clinician's Roadmap
17 mins • May 6, 2025
Charts
- 166Decreased by 34
- 197NEW
- 187Decreased by 25
- 174Decreased by 157
- 197Decreased by 6
Episodi recenti

May 6, 2025
Jesus G. Berdeja, MD - Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma With Bispecific Antibodies: A Community Clinician's Roadmap
17 mins

Apr 16, 2025
Aditya Bardia, MD / Sara Hurvitz, MD - Making a World of Difference for Patients With HER2-Low and -Ultralow Advanced Breast Cancer: Practical Strategies to Integrate Antibody-Drug Conjugates in Special Populations
30 mins

Apr 10, 2025
Komal Jhaveri, MD, FACP - Opportunities to Personalize Care: Making the Case for TROP2-Directed ADCs in HR+, HER2- Metastatic Breast Cancer
19 mins

Apr 10, 2025
Aditya Bardia, MD / Sara Hurvitz, MD - Realizing the Potential of Antibody-Drug Conjugates in HER2-Low and -Ultralow Advanced Breast Cancer: Evolving Strategies to Individualize Care
26 mins

Apr 4, 2025
Aditya Bardia, MD / Marilyn M. Bui, MD, PhD - Bringing HER2 Low and Ultralow to Light: How to Define and Detect HER2 Status in Advanced Breast Cancer
22 mins

Lingua
Inglese
Paese
Stati Uniti
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.